Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Circulating uromodulin inhibits systemic oxidative stress by inactivating the TRPM2 channel.

LaFavers KA, Macedo E, Garimella PS, Lima C, Khan S, Myslinski J, McClintick J, Witzmann FA, Winfree S, Phillips CL, Hato T, Dagher PC, Wu XR, El-Achkar TM, Micanovic R.

Sci Transl Med. 2019 Oct 2;11(512). pii: eaaw3639. doi: 10.1126/scitranslmed.aaw3639.

PMID:
31578243
2.

Hatched "egg" of thymoma with sarcoidosis.

Hato T, Yamaguchi M, Sugiyama A, Aoki K, Inoue Y, Fukuda H, Gika M, Higashi M, Nakayama M.

World J Surg Oncol. 2019 Aug 28;17(1):151. doi: 10.1186/s12957-019-1696-3.

3.

The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration.

Uchida M, Maier B, Waghwani HK, Selivanovitch E, Pay SL, Avera J, Yun E, Sandoval RM, Molitoris BA, Zollman A, Douglas T, Hato T.

J Clin Invest. 2019 Sep 3;129(9):3941-3951. doi: 10.1172/JCI127511.

4.

Automatic segmentation of intravital fluorescence microscopy images by K-means clustering of FLIM phasors.

Zhang Y, Hato T, Dagher PC, Nichols EL, Smith CJ, Dunn KW, Howard SS.

Opt Lett. 2019 Aug 15;44(16):3928-3931. doi: 10.1364/OL.44.003928.

PMID:
31415514
5.

Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.

Shigeta K, Datta M, Hato T, Kitahara S, Chen IX, Matsui A, Kikuchi H, Mamessier E, Aoki S, Ramjiawan RR, Ochiai H, Bardeesy N, Huang P, Cobbold M, Zhu AX, Jain RK, Duda DG.

Hepatology. 2019 Aug 5. doi: 10.1002/hep.30889. [Epub ahead of print]

PMID:
31378984
6.

Role of endotoxemia in causing renal dysfunction in cirrhosis.

Peng JL, Techasatian W, Hato T, Liangpunsakul S.

J Investig Med. 2019 Jul 19. pii: jim-2019-001056. doi: 10.1136/jim-2019-001056. [Epub ahead of print] Review.

PMID:
31324695
7.

Bacterial sepsis triggers an antiviral response that causes translation shutdown.

Hato T, Maier B, Syed F, Myslinski J, Zollman A, Plotkin Z, Eadon MT, Dagher PC.

J Clin Invest. 2019 Jan 2;129(1):296-309. doi: 10.1172/JCI123284. Epub 2018 Dec 3.

8.

Safe childbirth for a type 1 antithrombin-deficient woman with novel mutation in the SERPINC1 gene undergoing antithrombin concentrate therapy.

Ikeda Y, Yamanouchi J, Hato T, Yasukawa M, Takenaka K.

Blood Coagul Fibrinolysis. 2019 Jan;30(1):47-51. doi: 10.1097/MBC.0000000000000785.

PMID:
30431449
9.

[Therapeutic Effect and Adverse Events of Ramucirumab in Patients with Gastric Cancer in Our Hospital].

Tsuchiya H, Yamada M, Okumura N, Sugiyama Y, Goto A, Yokoi R, Sakuratani T, Sasaki Y, Matsui K, Osada S, Hato T.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1549-1551. Japanese.

PMID:
30382074
10.

Association of platelet response to cilostazol with clinical outcome and CYP genotype in patients with cerebral infarction.

Ikeda Y, Yamanouchi J, Kumon Y, Yasukawa M, Hato T.

Thromb Res. 2018 Dec;172:14-20. doi: 10.1016/j.thromres.2018.10.003. Epub 2018 Oct 10.

PMID:
30342278
11.

A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma.

Goyal L, Zheng H, Abrams TA, Miksad R, Bullock AJ, Allen JN, Yurgelun MB, Clark JW, Kambadakone A, Muzikansky A, Knowles M, Galway A, Afflitto AJ, Dinicola CF, Regan E, Hato T, Mamessier E, Shigeta K, Jain RK, Duda DG, Zhu AX.

Clin Cancer Res. 2019 Jan 1;25(1):80-89. doi: 10.1158/1078-0432.CCR-18-0847. Epub 2018 Sep 6.

12.

Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation.

Yamanouchi J, Tokumoto D, Ikeda Y, Maruta M, Kaneko M, Hato T, Yasukawa M.

Intern Med. 2018 Nov 1;57(21):3179-3182. doi: 10.2169/internalmedicine.1145-18. Epub 2018 Jun 6.

13.

Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.

Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, Bortfeld T, Wolfgang JA, Eyler CE, Goyal L, Clark JW, Crane CH, Koay EJ, Cobbold M, DeLaney TF, Jain RK, Zhu AX, Duda DG.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1222-1225. doi: 10.1016/j.ijrobp.2018.04.026. Epub 2018 Apr 17.

14.

Kidney Imaging: Intravital Microscopy.

Hato T, Winfree S, Dagher PC.

Methods Mol Biol. 2018;1763:129-136. doi: 10.1007/978-1-4939-7762-8_12.

15.

An unusual, CD4 and CD8 dual-positive, CD25 negative, tumor cell phenotype in a patient with adult T-cell leukemia/lymphoma.

Casey N, Fujiwara H, Azuma T, Murakami Y, Yoshimitsu M, Masamoto I, Nawa Y, Yamanouchi J, Narumi H, Yakushijin Y, Hato T, Yasukawa M.

Leuk Lymphoma. 2018 Nov;59(11):2740-2742. doi: 10.1080/10428194.2018.1439168. Epub 2018 Feb 21. No abstract available.

PMID:
29465309
16.

In Vivo siRNA Delivery and Rebound of Renal LRP2 in Mice.

Eadon MT, Cheng YH, Hato T, Benson EA, Ipe J, Collins KS, De Luca T, El-Achkar TM, Bacallao RL, Skaar TC, Dagher PC.

J Drug Deliv. 2017;2017:4070793. doi: 10.1155/2017/4070793. Epub 2017 Dec 20.

17.

Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.

Shankar Babu M, Mahanta S, Lakhter AJ, Hato T, Paul S, Naidu SR.

PLoS One. 2018 Feb 2;13(2):e0191419. doi: 10.1371/journal.pone.0191419. eCollection 2018.

18.

Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection.

Kolb AL, Corridon PR, Zhang S, Xu W, Witzmann FA, Collett JA, Rhodes GJ, Winfree S, Bready D, Pfeffenberger ZJ, Pomerantz JM, Hato T, Nagami GT, Molitoris BA, Basile DP, Atkinson SJ, Bacallao RL.

J Am Soc Nephrol. 2018 Apr;29(4):1154-1164. doi: 10.1681/ASN.2017060675. Epub 2018 Jan 25.

19.

Endothelial STAT3 Modulates Protective Mechanisms in a Mouse Ischemia-Reperfusion Model of Acute Kidney Injury.

Dube S, Matam T, Yen J, Mang HE, Dagher PC, Hato T, Sutton TA.

J Immunol Res. 2017;2017:4609502. doi: 10.1155/2017/4609502. Epub 2017 Oct 17.

20.

Tamm-Horsfall Protein Regulates Mononuclear Phagocytes in the Kidney.

Micanovic R, Khan S, Janosevic D, Lee ME, Hato T, Srour EF, Winfree S, Ghosh J, Tong Y, Rice SE, Dagher PC, Wu XR, El-Achkar TM.

J Am Soc Nephrol. 2018 Mar;29(3):841-856. doi: 10.1681/ASN.2017040409. Epub 2017 Nov 27.

21.

Endotoxin Preconditioning Reprograms S1 Tubules and Macrophages to Protect the Kidney.

Hato T, Zollman A, Plotkin Z, El-Achkar TM, Maier BF, Pay SL, Dube S, Cabral P, Yoshimoto M, McClintick J, Dagher PC.

J Am Soc Nephrol. 2018 Jan;29(1):104-117. doi: 10.1681/ASN.2017060624. Epub 2017 Oct 10.

22.

Mediastinal pulmonary artery is associated with greater artery diameter and lingular division volume.

Dejima H, Takahashi Y, Hato T, Seto K, Mizuno T, Kuroda H, Sakakura N, Kawamura M, Sakao Y.

Sci Rep. 2017 Apr 28;7(1):1273. doi: 10.1038/s41598-017-01384-1.

23.

Intravital microscopy of biosensor activities and intrinsic metabolic states.

Winfree S, Hato T, Day RN.

Methods. 2017 Sep 1;128:95-104. doi: 10.1016/j.ymeth.2017.04.017. Epub 2017 Apr 21.

24.

Intravital imaging of the kidney.

Hato T, Winfree S, Dagher PC.

Methods. 2017 Sep 1;128:33-39. doi: 10.1016/j.ymeth.2017.03.024. Epub 2017 Apr 12.

25.

Two-Photon Intravital Fluorescence Lifetime Imaging of the Kidney Reveals Cell-Type Specific Metabolic Signatures.

Hato T, Winfree S, Day R, Sandoval RM, Molitoris BA, Yoder MC, Wiggins RC, Zheng Y, Dunn KW, Dagher PC.

J Am Soc Nephrol. 2017 Aug;28(8):2420-2430. doi: 10.1681/ASN.2016101153. Epub 2017 Mar 1.

26.

Experimental Study of Intraparenchymal Fibrinogen and Topical Thrombin to Seal Pleural Defects.

Yamamoto J, Kohno M, Izawa N, Ema T, Hato T, Kamiyama I, Ohtsuka T, Watanabe M.

Tokai J Exp Clin Med. 2016 Dec 20;41(4):185-189.

27.

Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis.

Matsubara E, Yamanouchi J, Kitazawa R, Azuma T, Fujiwara H, Hato T, Yasukawa M.

Case Rep Hematol. 2016;2016:8751329. Epub 2016 Oct 20.

28.

Vancomycin-induced Immune Thrombocytopenia Proven by the Detection of Vancomycin-dependent Anti-platelet Antibody with Flow Cytometry.

Yamanouchi J, Hato T, Shiraishi S, Takeuchi K, Yakushijin Y, Yasukawa M.

Intern Med. 2016;55(20):3035-3038. Epub 2016 Oct 15.

29.

Successful rituximab treatment in an elderly patient with recurrent thrombotic thrombocytopenic purpura.

Matsubara E, Yamanouchi J, Hato T, Takeuchi K, Niiya T, Yasukawa M.

Rinsho Ketsueki. 2016 Jul;57(7):869-72. doi: 10.11406/rinketsu.57.869. Japanese.

PMID:
27498731
30.

Inhibition of Toll-Like Receptor 4 Signaling Mitigates Microvascular Loss but Not Fibrosis in a Model of Ischemic Acute Kidney Injury.

Dagher PC, Hato T, Mang HE, Plotkin Z, Richardson QV, Massad M, Mai E, Kuehl SE, Graham P, Kumar R, Sutton TA.

Int J Mol Sci. 2016 Apr 29;17(5). pii: E647. doi: 10.3390/ijms17050647.

31.

A novel frameshift mutation leading to inherited type I antithrombin deficiency.

Mori S, Yamanouchi J, Okamoto K, Hato T, Yasukawa M.

Blood Coagul Fibrinolysis. 2017 Mar;28(2):189-192. doi: 10.1097/MBC.0000000000000555.

PMID:
26974330
32.

Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.

Hato T, Zhu AX, Duda DG.

Immunotherapy. 2016;8(3):299-313. doi: 10.2217/imt.15.126. Epub 2016 Feb 11. Review.

33.

PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.

Incio J, Tam J, Rahbari NN, Suboj P, McManus DT, Chin SM, Vardam TD, Batista A, Babykutty S, Jung K, Khachatryan A, Hato T, Ligibel JA, Krop IE, Puchner SB, Schlett CL, Hoffmman U, Ancukiewicz M, Shibuya M, Carmeliet P, Soares R, Duda DG, Jain RK, Fukumura D.

Clin Cancer Res. 2016 Jun 15;22(12):2993-3004. doi: 10.1158/1078-0432.CCR-15-1839. Epub 2016 Feb 9.

34.

Novel application of complementary imaging techniques to examine in vivo glucose metabolism in the kidney.

Hato T, Friedman AN, Mang H, Plotkin Z, Dube S, Hutchins GD, Territo PR, McCarthy BP, Riley AA, Pichumani K, Malloy CR, Harris RA, Dagher PC, Sutton TA.

Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F717-F725. doi: 10.1152/ajprenal.00535.2015. Epub 2016 Jan 13.

35.

Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.

Incio J, Suboj P, Chin SM, Vardam-Kaur T, Liu H, Hato T, Babykutty S, Chen I, Deshpande V, Jain RK, Fukumura D.

PLoS One. 2015 Dec 7;10(12):e0141392. doi: 10.1371/journal.pone.0141392. eCollection 2015.

36.

Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection.

Takahashi Y, Kawamura M, Hato T, Harada M, Matsutani N, Horio H.

World J Surg. 2016 Feb;40(2):365-72.

PMID:
26493696
37.

A practical method for monitoring FRET-based biosensors in living animals using two-photon microscopy.

Tao W, Rubart M, Ryan J, Xiao X, Qiao C, Hato T, Davidson MW, Dunn KW, Day RN.

Am J Physiol Cell Physiol. 2015 Dec 1;309(11):C724-35. doi: 10.1152/ajpcell.00182.2015. Epub 2015 Sep 2. Review.

38.

Coincident detection of lung metastasis of prostate cancer and primary lung cancer: A case report.

Muro Y, Kosaka T, Hato T, Mikami S, Oya M.

Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E524-6. doi: 10.5489/cuaj.2376.

39.

A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice.

Eadon MT, Zhang H, Skaar TC, Hato T, Dagher PC, Gupta SK, Desta Z.

Antivir Chem Chemother. 2015 Apr;24(2):72-6. doi: 10.1177/2040206615595318. Epub 2015 Jul 30.

40.

An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.

Reiberger T, Chen Y, Ramjiawan RR, Hato T, Fan C, Samuel R, Roberge S, Huang P, Lauwers GY, Zhu AX, Bardeesy N, Jain RK, Duda DG.

Nat Protoc. 2015 Aug;10(8):1264-74. doi: 10.1038/nprot.2015.080. Epub 2015 Jul 23.

41.

Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.

Takahashi Y, Horio H, Hato T, Harada M, Matsutani N, Morita S, Kawamura M.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1324-31. doi: 10.1245/s10434-015-4735-5. Epub 2015 Jul 22.

PMID:
26198075
42.

A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia.

Yamanouchi J, Hato T, Kunishima S, Niiya T, Nakamura H, Yasukawa M.

Ann Hematol. 2015 Sep;94(9):1599-600. doi: 10.1007/s00277-015-2416-x. Epub 2015 Jun 9. No abstract available.

PMID:
26051904
43.

Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.

Takahashi Y, Horio H, Hato T, Harada M, Matsutani N, Kawamura M.

Interact Cardiovasc Thorac Surg. 2015 Jul;21(1):14-20. doi: 10.1093/icvts/ivv085. Epub 2015 Apr 15.

PMID:
25878187
44.

Virtual pathology of cervical radiculopathy based on 3D MR/CT fusion images: impingement, flattening or twisted condition of the compressed nerve root in three cases.

Kamogawa J, Kato O, Morizane T, Hato T.

Springerplus. 2015 Mar 12;4:123. doi: 10.1186/s40064-015-0898-6. eCollection 2015.

45.

Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanoma.

Lakhter AJ, Hamilton J, Dagher PC, Mukkamala S, Hato T, Dong XC, Mayo LD, Harris RA, Shekhar A, Ivan M, Brustovetsky N, Naidu SR.

Oncotarget. 2014 Dec 30;5(24):12694-703.

46.

Tamm-Horsfall Protein Regulates Granulopoiesis and Systemic Neutrophil Homeostasis.

Micanovic R, Chitteti BR, Dagher PC, Srour EF, Khan S, Hato T, Lyle A, Tong Y, Wu XR, El-Achkar TM.

J Am Soc Nephrol. 2015 Sep;26(9):2172-82. doi: 10.1681/ASN.2014070664. Epub 2015 Jan 2.

47.

The caspase 3 sensor Phiphilux G2D2 is activated non-specifically in S1 renal proximal tubules.

Hato T, Sandoval R, Dagher PC.

Intravital. 2015;4(2). pii: e1067352. Epub 2015 Aug 28.

48.

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.

Chen Y, Ramjiawan RR, Reiberger T, Ng MR, Hato T, Huang Y, Ochiai H, Kitahara S, Unan EC, Reddy TP, Fan C, Huang P, Bardeesy N, Zhu AX, Jain RK, Duda DG.

Hepatology. 2015 May;61(5):1591-602. doi: 10.1002/hep.27665. Epub 2015 Mar 20.

49.

Temporary extravascular shunt for reconstruction of a superior vena cava invaded by a lung tumor.

Yotsukura M, Kinoshita T, Kamiyama I, Hato T, Goto T, Ohtsuka T, Yoshitake A, Kudo M, Kohno M.

Ann Thorac Surg. 2014 Dec;98(6):2242-3. doi: 10.1016/j.athoracsur.2014.06.078. Epub 2014 Dec 1.

PMID:
25468109
50.

How the Innate Immune System Senses Trouble and Causes Trouble.

Hato T, Dagher PC.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1459-69. doi: 10.2215/CJN.04680514. Epub 2014 Nov 20. Review.

Supplemental Content

Support Center